Chartwell Investment Partners, LLC Intellia Therapeutics, Inc. Transaction History

Chartwell Investment Partners, LLC

  • $2.91 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 26, 2022
SELL
$58.27 - $118.99 $480,086 - $980,358
-8,239 Closed
0 $0
Q4 2021

Feb 15, 2022
SELL
$100.76 - $138.36 $15,920 - $21,860
-158 Reduced 1.88%
8,239 $974,000
Q3 2021

Nov 16, 2021
BUY
$132.37 - $176.78 $411,935 - $550,139
3,112 Added 58.88%
8,397 $1.13 Million
Q2 2021

Jul 19, 2021
BUY
$60.88 - $161.91 $321,750 - $855,694
5,285 New
5,285 $855,000

Others Institutions Holding NTLA

# of Institutions
336
Shares Held
96.1M
Call Options Held
1.06M
Put Options Held
863K
View Full List

About Intellia Therapeutics, Inc.

NTLA Quotes by TradingView
  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $925M
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track Chartwell Investment Partners, LLC Portfolio

Follow Chartwell Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chartwell Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chartwell Investment Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email